Repositorio Dspace

Adding metabolic tasks to human GEM models to improve the study of gene targets and their associated toxicities

Mostrar el registro sencillo del ítem

dc.contributor.author Guil, Francisco
dc.contributor.author García, Raquel
dc.contributor.author García, José-M
dc.date.accessioned 2025-11-26T11:46:58Z
dc.date.available 2025-11-26T11:46:58Z
dc.date.issued 2024-07
dc.identifier.citation Guil F, García R, García JM. Adding metabolic tasks to human GEM models to improve the study of gene targets and their associated toxicities. Sci Rep. 27 de julio de 2024;14(1):17265.
dc.identifier.issn 2045-2322
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22697
dc.description.abstract Genetic minimal cut sets (gMCS) are genes that must be deactivated simultaneously to avoid unwanted states in a metabolic model. The concept of gMCS can be applied to two different scenarios. First, it can be used to identify potential gene toxicities in generic or healthy cell models. Second, it can be used to develop genetic strategies to target cancer cells and prevent their proliferation. Up to now, gMCS have been evaluated using the traditional procedure of preventing biomass production. This paper proposes an additional way: using essential metabolic tasks, which any human cell should perform, to enlarge the set of unwanted states. Including this addition can significantly improve the study of toxicities and reveal targets that can be used to treat unhealthy cells. Excluding metabolic tasks can cause important information to be overlooked, which could impact the study's success. Regarding toxicities, using the generic Human model, the number of detected generic toxicities with metabolic tasks increases from 106 to 281 (136 gMCSs of length 1 and 49 of length 2). We have used the following context-specific models to evaluate specific toxicities in different healthy tissues: blood, pancreas, liver, heart, and kidney. Again, considering metabolic tasks, we have found new toxicities (lengths 1 and 2) whose inactivation could damage these healthy tissues.Our research strategy has been applied to identify new cancer drug targets in two myeloma cell lines. We obtained new therapeutic targets of lengths 1 and 2 for each cell line. After analyzing the data, we conclude that incorporating metabolic tasks into cancer models can reveal important therapeutic targets previously disregarded by the conventional method of inhibiting biomass production. This approach also improves the evaluation of potential drug toxicities.
dc.language.iso eng
dc.publisher NATURE PORTFOLIO
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0 *
dc.subject.mesh Humans
dc.subject.mesh Models, Biological
dc.subject.mesh Neoplasms/genetics/drug therapy/metabolism
dc.title Adding metabolic tasks to human GEM models to improve the study of gene targets and their associated toxicities
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 39068208
dc.relation.publisherversion https://www.nature.com/articles/s41598-024-68073-8
dc.identifier.doi 10.1038/s41598-024-68073-8
dc.journal.title Scientific Reports


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta